The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems.
from MobiHealthNews http://ift.tt/2BZOJqr
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment